Health

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT for Parkinsons Disease

December 05, 2025 08:00 ET  | Source: Amneal Pharmaceuticals LLC Interim data show substantial improvements in “Good On” time compared…

2 weeks ago

Renuka Iyer, MD, Named New Chief Medical Officer for National Comprehensive Cancer Network (NCCN)

Acclaimed oncologist from Roswell Park Comprehensive Cancer Center to help lead nonprofit responsible for gold standard guidelines that define and…

2 weeks ago

Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance

Powered by agentic AI, new features help regulatory teams improve accuracy and enable faster, more confident decisions across the product…

2 weeks ago

McLaren Bay Region Raises the Bar on Emergency Department Communication with MEDI+SIGN

BAY CITY, Mich., Dec. 04, 2025 (GLOBE NEWSWIRE) -- McLaren Bay Region has equipped its Emergency Department treatment rooms with…

2 weeks ago

Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine

AGOURA HILLS, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano today…

2 weeks ago

American Society of Clinical Oncology (ASCO) announces dates for 2026 ASCO Breakthrough and begins accepting submissions for novel oncology research

Global oncology society calls for abstract submissions for research that is shaping the future of cancer care in advance of…

2 weeks ago

Emerald Clinical Appoints Luke Gill as Vice President, Global Head of Oncology, Medical & Scientific Affairs

Accomplished biotech and CRO leader brings 25+ years of global oncology drug development and operational excellence to propel Emerald's continued…

2 weeks ago

Nika Pharmaceuticals, Inc. (NIKA) Progress Update

HENDERSON, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) appeared on The Street Reports podcast where…

2 weeks ago

Carl H. Sharperson III Joins MATTER Board of Directors

December 03, 2025 10:00 ET  | Source: MATTER MINNEAPOLIS, MN , Dec. 03, 2025 (GLOBE NEWSWIRE) -- MATTER, a Minnesota-based…

2 weeks ago

THE U.S. POINTER STRUCTURED HEALTHY LIFESTYLE PROGRAM — PREVIOUSLY SHOWN TO IMPROVE COGNITION — MAY ALSO IMPROVE SLEEP APNEA, BLOOD PRESSURE REGULATION, AND COGNITIVE RESILIENCE

- Two-year lifestyle intervention "recipe" tested in three NIH-funded ancillary studies -Key TakeawaysFindings from three NIA-funded ancillary studies to the U.S.…

2 weeks ago